Duloxetine |
Cymbalta |
Clinical Trial: Study of Duloxetine in Elderly Patients with Major Depressive Disorder
This study is no longer recruiting patients.
|
Purpose
A study of the safety and efficacy of duloxetine in elderly patients (greater than 65 years old) with major depressive disorder
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Depression, Cognition | Drug: Duloxetine Drug: "Investigational Drug" | Phase III |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Treatment
Eligibility
Ages Eligible for Study: 65 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion Criteria: 1. You must be able to visit the doctor's office for clinic visits, tests, and procedures. 2. You must have been diagnosed with major depression, and have had at least one other episode in the past.
Exclusion Criteria: 1. You have a current or previous major psychiatric disorder other than depression, such as bipolar disorder, schizophrenia, or other psychotic disorder. 2. You have taken a drug within the last 30 days that has not been approved for use by governmental authorities.
Location Information
California
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Chula Vista, California, United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Rosemead, California, United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Beverly Hills, California, United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Menlow Park, California, United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., San Francisco, California, United States
Connecticut
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Cromwell, Connecticut, United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Hamden, Connecticut, United States
Florida
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Clearwater, Florida, United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., St. Petersburg, Florida, United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Winter Park, Florida, United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Port Charlotte, Florida, United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician., West Palm Beach, Florida, United States
Indiana
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Indianapolis, Indiana, United States
Kansas
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Wichita, Kansas, United States
Louisiana
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., New Orleans, Louisiana, United States
Maryland
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Baltimore, Maryland, United States
Massachusetts
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Belmont, Massachusetts, United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Boston, Massachusetts, United States
Missouri
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Chesterfield, Missouri, United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Kansas City, Missouri, United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., St. Louis, Missouri, United States
New Jersey
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Clementon, New Jersey, United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Toms River, New Jersey, United States
New Mexico
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Albuquerque, New Mexico, United States
New York
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Olean, New York, United States
Oklahoma
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Oklahoma City, Oklahoma, United States
Pennsylvania
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Philadelphia, Pennsylvania, United States
Rhode Island
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Warwick, Rhode Island, United States
Tennessee
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Johnson City, Tennessee, United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Nashville, Tennessee, United States
Texas
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Austin, Texas, United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Houston, Texas, United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Lake Jackson, Texas, United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician., Dallas, Texas, United States
Utah
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Salt Lake City, Utah, United States
Washington
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Seattle, Washington, United States
Wisconsin
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., West Allias, Wisconsin, United States
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Middleton, Wisconsin, United States
Puerto Rico
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY (1-877-295-4559) or speak with your personal physician., Santurce, Puerto Rico
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician., Ponce, Puerto Rico
More Information
Record last reviewed: July 2004
Last Updated: October 13, 2004
Record first received: June 10, 2003
ClinicalTrials.gov Identifier: NCT00062673
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


